| Edward P Stack, MD | |
|
5300 Gateway Ctr, Flint, MI 48507-3930 | |
| (810) 720-9111 | |
| (810) 720-9119 |
| Full Name | Edward P Stack |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 33 Years |
| Location | 5300 Gateway Ctr, Flint, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801899885 | NPI | - | NPPES |
| 15474 | Other | MA | SPECTERA |
| 5100110 | Other | MI | AETNA |
| 4774225 | Medicaid | MI | |
| C6993 | Other | MI | MCARE |
| 6736673005 | Other | MI | CIGNA |
| 110201 | Other | MI | CARE CHOICES |
| 1802511821 | Other | MI | BCBSM |
| 4301065179 | Other | MI | STATE LICENSE NUMBER |
| 000000010198 | Other | MI | CAPE MEDICAID |
| 028341 | Other | MI | MIDWEST HEALTH |
| 4604520 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301065179 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Vision Institute Pllc | 1658317748 | 5 |
News Archive
An 18-year follow-up study of postmenopausal women in the Women's Health Initiative trials has shown that the use of hormone therapy was not associated with any increased risk of all-cause, cardiovascular or cancer death.
Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
There is an increasing prevalence of substance problems in older people but a lack of designated service provision to help treat older addicts highlights an editorial published today in Age & Ageing, the official journal of the British Geriatrics Society.
› Verified 3 days ago
| Entity Name | Michigan Vision Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780746081 PECOS PAC ID: 1658317748 Enrollment ID: O20050629000285 |
News Archive
An 18-year follow-up study of postmenopausal women in the Women's Health Initiative trials has shown that the use of hormone therapy was not associated with any increased risk of all-cause, cardiovascular or cancer death.
Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
There is an increasing prevalence of substance problems in older people but a lack of designated service provision to help treat older addicts highlights an editorial published today in Age & Ageing, the official journal of the British Geriatrics Society.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward P Stack, MD 5300 Gateway Ctr, Flint, MI 48507-3930 Ph: (810) 720-9111 | Edward P Stack, MD 5300 Gateway Ctr, Flint, MI 48507-3930 Ph: (810) 720-9111 |
News Archive
An 18-year follow-up study of postmenopausal women in the Women's Health Initiative trials has shown that the use of hormone therapy was not associated with any increased risk of all-cause, cardiovascular or cancer death.
Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today reported financial results for the three and 12 months ended December 31, 2009.
There is an increasing prevalence of substance problems in older people but a lack of designated service provision to help treat older addicts highlights an editorial published today in Age & Ageing, the official journal of the British Geriatrics Society.
› Verified 3 days ago
Dr. Steven Allen Boskovich, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1290 S Linden Rd, Flint, MI 48532 Phone: 810-732-6231 Fax: 810-732-0725 | |
Dr. Aman Khaled Shukairy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1160 S Linden Rd, Flint, MI 48532 Phone: 810-820-8230 Fax: 810-820-8937 | |
Dr. David A Diskin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111 Fax: 810-733-7141 | |
John A Waters, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5055 W Bristol Rd, Flint, MI 48507 Phone: 810-732-2272 Fax: 810-732-8470 | |
Dr. Jeffrey A Diskin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111 Fax: 810-733-7141 | |
Dr. Gary M Keoleian, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4499 Town Center Pkwy, Flint, MI 48532 Phone: 810-733-7111 Fax: 810-733-7141 | |
Daniel Joseph Ryan, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1113 Villa Linde Ct, Flint, MI 48532 Phone: 810-733-1214 Fax: 810-733-3011 |